Daijiworld Media Network - New Delhi

New Delhi, Apr 13: Scientists have reported encouraging results from early trials of a new malaria vaccine, raising hopes of stronger protection against one of the world’s deadliest infectious diseases.

Researchers said the experimental vaccine has shown higher effectiveness compared to existing options in preventing infection caused by Malaria, particularly among children and vulnerable populations in high-risk regions.

The vaccine works by boosting the body’s immune response to block the parasite at an early stage, preventing it from entering the bloodstream and causing severe illness.

Health experts believe this development could significantly reduce malaria-related deaths, especially in parts of Africa and Asia where the disease remains a major public health challenge.

Global health organisations, including World Health Organization, have welcomed the findings, noting that improved vaccines are critical to achieving long-term malaria control and eventual elimination.

Further large-scale trials are expected in the coming months to confirm safety and effectiveness before wider rollout.

If successful, the vaccine could become a major milestone in global efforts to combat malaria and improve child health outcomes.